Application

17419163 · PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND FORMULATIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES IMPACTED BY IL-6 DYSREGULATION

Filed 2021-06-28 · Granted · Patent 12350322 (2025-07-08) The official file ↗The patent and its PDF ↗ · Art unit 1674 · Examiner Prema Maria Mertz Easy · CPC A61K 39/0008 · UNITED BIOMEDICAL, INC. · Locke Lord LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

32.7 mo

to disposition 48.3 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.